Literature DB >> 28804838

Platelet Function Tests: Preanalytical Variables, Clinical Utility, Advantages, and Disadvantages.

Anne-Mette Hvas1, Erik Lerkevang Grove2.   

Abstract

Platelet function tests are mainly used in the diagnostic work-up of platelet disorders. During the last decade, the additional use of platelet function tests to evaluate the effect of antiplatelet therapy has also emerged in an attempt to identify patients with an increased risk of arterial thrombosis. Furthermore, platelet function tests are increasingly used to measure residual effect of antiplatelet therapy prior to surgery with the aim of reducing the risk of bleeding. To a limited extend, platelet function tests are also used to evaluate hyperaggregability as a potential marker of a prothrombotic state outside the setting of antiplatelet therapy. This multifaceted use of platelet function tests and the development of simpler point-of-care tests with narrower application have increased the use of platelet function testing and also facilitated the use of platelet function tests outside the highly specialized laboratories. The present chapter describes the preanalytical variables, which should be taken into account when planning platelet function testing. Also, the most widely used platelet function tests are introduced, and their clinical utility and their relative advantages and disadvantages are discussed.

Entities:  

Keywords:  Antiplatelet therapy; Bleeding disorders; Flow cytometry; Impedance aggregometry; Light transmission aggregometry; Platelet aggregometry; Platelet function testing; Point-of-care systems; Thrombosis

Mesh:

Substances:

Year:  2017        PMID: 28804838     DOI: 10.1007/978-1-4939-7196-1_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention.

Authors:  Adam Wiśniewski
Journal:  Medicina (Kaunas)       Date:  2021-01-10       Impact factor: 2.430

2.  Unfavorable Changes of Platelet Reactivity on Clopidogrel Therapy Assessed by Impedance Aggregometry Affect a Larger Volume of Acute Ischemic Lesions in Stroke.

Authors:  Adam Wiśniewski; Joanna Sikora; Aleksandra Karczmarska-Wódzka; Przemysław Sobczak; Adam Lemanowicz; Elżbieta Zawada; Rytis Masiliūnas; Dalius Jatužis
Journal:  Diagnostics (Basel)       Date:  2021-02-27

Review 3.  The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke-Between Benefit and Risk: A Systematic Review.

Authors:  Joanna Sikora; Aleksandra Karczmarska-Wódzka; Joanna Bugieda; Przemysław Sobczak
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923

4.  Predictive value of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in evaluating both lung involvement and severity of patients with coronavirus disease 2019.

Authors:  Yusuf Aksu; Ali U Uslu; Gülten Tarhan; Mustafa Karagülle
Journal:  Saudi Med J       Date:  2021-11       Impact factor: 1.422

5.  Platelet electrical resistance for measuring platelet activation and adhesion in human health and disease.

Authors:  Travis M Griffiths; Lauren Page; Andrew S Weyrich; Matthew T Rondina; Robert A Campbell
Journal:  Thromb Res       Date:  2020-12-18       Impact factor: 3.944

Review 6.  The Phenomenon of Clopidogrel High On-Treatment Platelet Reactivity in Ischemic Stroke Subjects: A Comprehensive Review.

Authors:  Adam Wiśniewski; Karolina Filipska
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.